Joshua Z Drago

10PUBLICATIONS
35CO-AUTHORS
Molecular targetsClinical midwiferyCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 09, 2026
ERBB2 Activating Mutations Promote Enhanced Internalization and Activity of Trastuzumab Deruxtecan in HER2-non-amplified Metastatic Breast Cancer.

|Nov 10, 2025
Trastuzumab Deruxtecan Resistance via Loss of HER2 Expression and Binding.

Wanyi Chen, Avantika Gupta, Nicholas Mai

|May 29, 2025
Sequential Antibody-Drug Conjugate Therapy in Patients With Metastatic Breast Cancer Treated With Sacituzumab Govitecan and Trastuzumab Deruxtecan.

|Apr 03, 2023
ADCs or: How I Learned to Stop Worrying and Love Chemotherapy.

Avantika Gupta, Joshua Z Drago, Sarat Chandarlapaty

|Oct 20, 2021
Morphologic and Genomic Characteristics of Breast Cancers Occurring in Individuals with Lynch Syndrome.

Christopher J Schwartz, Edaise M da Silva, Antonio Marra

|May 05, 2021
A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with PIK3CA-Mutated HER2-Positive Metastatic Breast Cancer.

Komal Jhaveri, Joshua Z Drago, Payal Deepak Shah

Pageof 2

Frequent Collaborators

6 joint publications

Sarat Chandarlapaty

4 joint publications

Shanu Modi

3 joint publications

Pedram Razavi

3 joint publications

Nicholas Mai